Rizvi Syed Ali-aamir has filed 5 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 61963 shares of ROCKET PHARMACEUTICALS, INC. ($RCKT) on February 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Rizvi Syed Ali-aamir | Chief Medical Officer | A | Common Stock | 61963 | $0.00 | 407,874.0000 | 111,571,136 | 17.91% | 0.06% |
| Feb. 11, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Rizvi Syed Ali-aamir | Chief Medical Officer | A | Stock Option (right to buy) | 93037 | $0.00 | 93,037.0000 | 111,571,136 | 9999.99% | 0.08% |
| Oct. 6, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Rizvi Syed Ali-aamir | Chief Medical Officer | A | Common Stock | 283018 | $0.00 | 283,018.0000 | 111,571,136 | 9999.99% | 0.25% |
| Oct. 6, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Rizvi Syed Ali-aamir | Chief Medical Officer | A | Common Stock | 62893 | $0.00 | 345,911.0000 | 111,571,136 | 22.22% | 0.06% |
| Oct. 6, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Rizvi Syed Ali-aamir | Chief Medical Officer | A | Stock Option (right to buy) | 383854 | $0.00 | 383,854.0000 | 111,571,136 | 9999.99% | 0.34% |